DWIGHT WESLEY J
No ORCID on file
· 36 papers in corpus
· active 2000-2009
Frequent coauthors
- HAVIV Fortuna 24
- GREER Jonathan 24
- NICHOLS Charles J. 24
- HUANG CHARLES Q 12
- TUCCI FABIO C 12
- WU DONGPEI 12
- CHEN CHEN 12
- WADE WARREN 12
- CHEN YONGSHENG 12
- GUO ZHIQIANG 12
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2001
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…
2000
The present invention relates to a class of heptapeptide analogs of LHRH. These compounds are useful in the treatment of disease conditions which are mediated by reproductive hormones, including benign prostate hyperplasia, prostate tumors,…